Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Saved in:
Bibliographic Details
Title: Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.
Authors: Wehbe E; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia., Sreeharan T; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia., Sutrave G; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia., Bui J; Department of Pharmacy, Royal North Shore Hospital, Sydney, NSW 2065, Australia., Lau C; Department of Pharmacy, St Vincent's Hospital, Sydney, NSW 2010, Australia., Park JY; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia., Sandaradura I; Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia.; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, NSW 2145, Australia.; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW 2145, Australia., Darley D; Department of Thoracic Medicine, St Vincent's Hospital, Sydney, NSW 2010, Australia., Macdonald P; Heart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW 2010, Australia., Milliken S; Department of Haematology, St Vincent's Hospital, Sydney, NSW 2010, Australia., Fung JN; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia., Jones G; Department of Chemical Pathology and Clinical Pharmacology, SydPath, St Vincent's Hospital, Sydney, NSW 2010, Australia., Kizny Gordon A; Department of Infectious Diseases and Microbiology, Royal North Shore Hospital, Sydney, NSW 2065, Australia., Kliman D; Department of Haematology, Royal North Shore Hospital, Sydney, NSW 2065, Australia., Lu CY; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.; Department of Pharmacy, Royal North Shore Hospital, Sydney, NSW 2065, Australia.; Kolling Institute, Faculty of Medicine and Health, The University of Sydney, The Northern Sydney Local Health District, Sydney, NSW 2065, Australia., Marriott D; Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital, Sydney, NSW 2010, Australia., Alffenaar JC; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia.; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW 2145, Australia., Stocker SL; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.; Department of Pharmacy, Westmead Hospital, Sydney, NSW 2145, Australia.; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW 2145, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW 2010, Australia.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2026 May 05; Vol. 81 (6).
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1460-2091
DOI:10.1093/jac/dkag168